机译:Re: Adjuvant Atezolizumab Versus Placebo for Patients with Renal Cell Carcinoma at Increased Risk of Recurrence Following Resection (IMmotion010): A Multicentre, Randomised, Double-blind, Phase 3 Trial
Department of Urology Shanghai Changhai Hospital Naval Medical University;
Department of Neurosciences Reproductive Sciences and Odontostomatology University of Naples;
Department of Urology Rush University Medical Center;